Acadian Asset Management
EVLO

Acadian Asset Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Acadian Asset Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-47,775
Closed -$2K – 1861
2023
Q4 		$2K Buy
+47,775
New +$53.2K ﹤0.01% 1651
2021
Q3 		– Sell
-78
Closed -$21K – 2104
2021
Q2 		$21K Buy
+78
New +$19.7K ﹤0.01% 1941

Acadian Asset Management's EVLO Position: Q1 2024 in Review

Acadian Asset Management sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2024, closing a stake of 47,775 shares — an estimated $2K sold.

Acadian Asset Management first reported a position in EVLO in Q2 2021 and held it in 2 quarters. The position peaked at $21K in Q2 2021. 0 funds tracked by Wall St. Rank hold EVLO as of Q1 2024.

  • Acadian Asset Management reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 47,775 Evelo Biosciences, Inc. Common Stock shares in Q1 2024, an estimated $2K.
  • Acadian Asset Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Acadian Asset Management's Evelo Biosciences, Inc. Common Stock position peaked at $21K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.